BGLC vs CFG · rev $99.0K vs P/E 15, rev $2.28B
BioNexus Gene Lab Corp Common stock (BGLC) versus Citizens Financial Group, Inc. (CFG) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Citizens Financial Group, Inc. (CFG) is a banks - regional company listed on US.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported CFG revenue for 2026-06-30 was $2.28B. Net income was $587.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
BGLC currently screens at market cap $6.1M. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
Not investment advice. Open the BGLC and CFG stock pages for the full models.
Not investment advice.